Literature DB >> 7614977

Selective variations in vivo of VH3 and VH1 gene family expression in peripheral B cell IgM, IgD and IgG during HIV infection.

D David1, C Demaison, L Bani, M Zouali, J Thèze.   

Abstract

We have analyzed the expression of VH gene families in IgM, IgD and IgG of peripheral blood B cells from a group of HIV-infected patients. CD19+CD20+ cells were purified and anchored reverse transcriptase-polymerase chain reaction products were hybridized with VH gene family probes. IgM, IgD and IgG that expressed a VH3 gene family segment, were decreased in patients with low CD4 counts and to a greater extend in patients with AIDS symptoms (up to 85% for IgG) compared to adult healthy donors. This was correlated with elevated levels of IgM and IgG encoded by a VH1 gene family segment (around 60% for IgG). These results confirm and extend previous work that has detected the VH3 gene family under-representation in HIV infection. Here, we show that, in vivo, this phenomenon actually affects the different B cell populations of the peripheral blood: IgM+ or IgG+ B cells and also IgM+IgD+ naive B cells. In the course of HIV infection, this results in their gradual depletion. Data presented here strengthen the hypothesis that a B-cell superantigen exists in HIV infection. These pronounced variations of the normally most-expressed VH gene family may be related to B cell abnormalities detected in HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614977     DOI: 10.1002/eji.1830250608

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Immunoglobulin V(H) usage during primary infection of rhesus monkeys with chimeric simian-human immunodeficiency viruses.

Authors:  D H Margolin; K A Reimann; J Sodroski; G B Karlsson; K Tenner-Racz; P Racz; N L Letvin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1.

Authors:  Miroslaw K Gorny; Xiao-Hong Wang; Constance Williams; Barbara Volsky; Kathy Revesz; Bradley Witover; Sherri Burda; Mateusz Urbanski; Phillipe Nyambi; Chavdar Krachmarov; Abraham Pinter; Susan Zolla-Pazner; Arthur Nadas
Journal:  Mol Immunol       Date:  2008-10-25       Impact factor: 4.407

3.  Long-term kinetics of adult human antibody repertoires.

Authors:  Iris Van Dijk-Härd; Inger Lundkvist
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

Review 4.  Phages and HIV-1: from display to interplay.

Authors:  Sylvie Delhalle; Jean-Claude Schmit; Andy Chevigné
Journal:  Int J Mol Sci       Date:  2012-04-13       Impact factor: 6.208

5.  Comparison of antibody repertoires produced by HIV-1 infection, other chronic and acute infections, and systemic autoimmune disease.

Authors:  Felix Breden; Christa Lepik; Nancy S Longo; Marinieve Montero; Peter E Lipsky; Jamie K Scott
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

6.  Different pattern of immunoglobulin gene usage by HIV-1 compared to non-HIV-1 antibodies derived from the same infected subject.

Authors:  Liuzhe Li; Xiao-Hong Wang; Sagarika Banerjee; Barbara Volsky; Constance Williams; Diana Virland; Arthur Nadas; Michael S Seaman; Xuemin Chen; Paul Spearman; Susan Zolla-Pazner; Miroslaw K Gorny
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

7.  TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice.

Authors:  Véronique Godot; Colas Tcherakian; Laurine Gil; Iñaki Cervera-Marzal; Guangming Li; Liang Cheng; Nicolas Ortonne; Jean-Daniel Lelièvre; Giuseppe Pantaleo; Craig Fenwick; Mireille Centlivre; Hugo Mouquet; Sylvain Cardinaud; Sandra M Zurawski; Gerard Zurawski; Pierre Milpied; Lishan Su; Yves Lévy
Journal:  PLoS Pathog       Date:  2020-11-30       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.